Brazzelli, MiriamCruickshank, MoiraTassie, EmmaMcNamee, PaulRobertson, ClareElders, AndrewFraser, CynthiaHernandez, RodolfoLawrie, DavidRamsay, Craig2016-02-252016-02-252015-10Brazzelli, M, Cruickshank, M, Tassie, E, McNamee, P, Robertson, C, Elders, A, Fraser, C, Hernandez, R, Lawrie, D & Ramsay, C 2015, 'Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture : systematic review and economic evaluation', Health Technology Assessment, vol. 19, no. 90, pp. 1-202. https://doi.org/10.3310/hta199001366-5278ORCID: /0000-0002-5182-884X/work/69663735ORCID: /0000-0003-4043-7349/work/84131506ORCID: /0000-0003-2619-8230/work/159078527http://hdl.handle.net/2164/5550Source of funding This report was commissioned by the National Institute for Health Research (NIHR) HTA programme as project number 13/05/01. The Health Services Research Unit and Health Economics Research Unit are core-funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. The views and opinions expressed are those of the authors and do not necessarily reflect those of the funders.20214313860engSDG 3 - Good Health and Well-beingR MedicineNational Institute for Health Research (NIHR)13/05/01RCollagenase clostridium histolyticum for the treatment of Dupuytren’s contracture : systematic review and economic evaluationJournal article10.3310/hta199001990